Latest Payments News

Iperion reported a lower loss for the year ended 31 March 2026, but its cash reserves and net assets fell sharply, leaving the NZX-listed materials company reliant on related-party funding and director support. Its Pathoglaze manufacturing operation is also being moved from Malaysia to Singapore while customer trials continue.

Wildcat Resources has entered FY27 with a $60 million placement, a $37.2 million year-end cash balance and its Tabba Tabba lithium project advancing towards a definitive feasibility study. The funding strengthens the development runway, but final investment approval, financing and approvals remain ahead.

Charger Metals has reduced its FY2026 loss and secured $3.75 million from the sale of Bynoe, giving the lithium explorer more room to advance its Lake Johnston assets. The company’s Medcalf resource now stands at 10.6Mt, although further drilling and funding will be needed to test its economic potential.

Walter Scott Global Equity Fund’s operating profit fell to A$4.1 million in 2026 from A$349.5 million, while net assets dropped by about A$1.1 billion. The audited report points to weaker investment gains and substantial redemptions, although the fund remained fully invested in quoted equities and received an unmodified audit opinion.

Pengana International Equities has cancelled 151.1 million shares in a $183.28 million buy-back, leaving a much smaller listed investment company and three fewer directors. The reconstituted board will review capital options before deciding whether to pursue a future rights issue.

Mayne Pharma has settled patent litigation with Sun Pharma over IMVEXXY, establishing 21 October 2032 as the agreed potential generic entry date, subject to court approval. The settlement involves no upfront payment, while one further Paragraph IV dispute remains unresolved.

AnteoTech has set sales conversion as its FY2027 priority after FY2026 sales revenue slipped to A$460,397, while operating expenses fell sharply and cash stood at A$11.2 million. The battery materials and life sciences company says customer evaluations and partnership discussions are building, but most opportunities remain short of recurring commercial revenue.

PDI Gold’s first full annual report after its Robex merger shows a transformed West African gold business with US$193.7 million in cash and two producing mines. The statutory result remains a US$63.7 million loss, while Bankan’s next phase still depends on an exploitation permit from Guinea.

Yugo Metals finished 2026 with A$6.29 million in cash after raising A$8.6 million, giving its Bosnia and Herzegovina exploration program more financial room. The trade-off was a net loss of A$3.93 million, more than double the previous year, alongside substantial equity issuance and ongoing funding risk.

Resolution Minerals has turned Horse Heaven into the centre of its strategy, pairing broad gold drilling with high-grade antimony and tungsten test work. The expansion came with a sharply higher A$53.3 million FY2026 loss and a disclosed dependence on future funding.

Novatti has reported a statutory profit and positive EBITDA for FY26 after cutting low-margin revenue and concentrating on Payments AU/NZ. The turnaround is substantial, but an auditor-flagged going-concern uncertainty, upcoming debt maturities and negative operating cash flow leave the recovery unfinished.

European Metals will temporarily lose 6.38 percentage points of its Geomet stake after CEZ agreed to fund a EUR13 million cash call. The company intends to buy back the interest for EUR6.448 million, but must first secure financing by 13 November 2026.